No Maintenance, No Gain in Long-term Treatment of Eosinophilic Esophagitis.
作者信息
Dellon Evan S
机构信息
Center for Esophageal Diseases and Swallowing, Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
出版信息
Clin Gastroenterol Hepatol. 2019 Feb;17(3):397-399. doi: 10.1016/j.cgh.2018.07.038.
Abstract
摘要
相似文献
1
No Maintenance, No Gain in Long-term Treatment of Eosinophilic Esophagitis.
Clin Gastroenterol Hepatol. 2019 Feb;17(3):397-399. doi: 10.1016/j.cgh.2018.07.038.
2
Maintenance Treatment of Eosinophilic Esophagitis with Swallowed Topical Steroids Alters Disease Course - Defining Treatment Goals.
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2384-2385. doi: 10.1016/j.cgh.2019.04.028. Epub 2019 Apr 17.
3
The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?
J Gastroenterol. 2018 Feb;53(2):165-171. doi: 10.1007/s00535-017-1397-z. Epub 2017 Oct 10.
4
Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients.
Clin Gastroenterol Hepatol. 2019 Feb;17(3):419-428.e6. doi: 10.1016/j.cgh.2018.05.045. Epub 2018 Jun 11.
5
Sticky Steroids: In Search of an Approved Treatment for Eosinophilic Esophagitis.
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):172-173. doi: 10.1097/MPG.0000000000001326.
6
Steroid treatment of eosinophilic esophagitis in adults.
Gastroenterol Clin North Am. 2014 Jun;43(2):357-73. doi: 10.1016/j.gtc.2014.02.001. Epub 2014 Mar 24.
7
Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future.
Dis Esophagus. 2011 May;24(4):229-34. doi: 10.1111/j.1442-2050.2010.01134.x. Epub 2010 Nov 12.
8
Editorial: Deep Remission in Eosinophilic Esophagitis With Long-Term Steroids: Difficult to Attain and Maintain.
Am J Gastroenterol. 2017 Oct;112(10):1536-1537. doi: 10.1038/ajg.2017.267.
9
Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis.
Clin Gastroenterol Hepatol. 2017 Jun;15(6):841-849.e1. doi: 10.1016/j.cgh.2016.11.032. Epub 2016 Dec 7.
10
Most children with eosinophilic esophagitis have a favorable outcome as young adults.
Dis Esophagus. 2017 Jan 1;30(1):1-6. doi: 10.1111/dote.12454.
引用本文的文献
1
Effect of randomized treatment withdrawal of budesonide oral suspension on clinically relevant efficacy outcomes in patients with eosinophilic esophagitis: a post hoc analysis.
Therap Adv Gastroenterol. 2024 Dec 23;17:17562848241307602. doi: 10.1177/17562848241307602. eCollection 2024.
2
Eosinophilic gastrointestinal disorders: a narrative review on clinical perspectives and research gaps in the Asian context.
Transl Gastroenterol Hepatol. 2024 Aug 23;9:69. doi: 10.21037/tgh-24-34. eCollection 2024.
3
Improved Outcomes in Eosinophilic Esophagitis with Higher Medication Possession Ratio.
Medicines (Basel). 2024 Mar 26;11(4):8. doi: 10.3390/medicines11040008.
4
Esophageal Dysphagia in the Elderly.
Curr Treat Options Gastroenterol. 2019 Dec;17(4):534-553. doi: 10.1007/s11938-019-00264-z.
本文引用的文献
1
Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review.
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1714-1729.e3. doi: 10.1016/j.cgh.2018.06.005. Epub 2018 Jun 14.
2
Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis.
Clin Gastroenterol Hepatol. 2019 Mar;17(4):666-673.e8. doi: 10.1016/j.cgh.2018.05.051. Epub 2018 Jun 12.
3
Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients.
Clin Gastroenterol Hepatol. 2019 Feb;17(3):419-428.e6. doi: 10.1016/j.cgh.2018.05.045. Epub 2018 Jun 11.
4
The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort.
Am J Gastroenterol. 2018 Jun;113(6):836-844. doi: 10.1038/s41395-018-0052-5. Epub 2018 Apr 27.
5
Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.
Dis Esophagus. 2017 Jul 1;30(7):1-7. doi: 10.1093/dote/dox042.
6
Progression from an Inflammatory to a Fibrostenotic Phenotype in Eosinophilic Esophagitis.
Case Rep Gastroenterol. 2017 Jun 15;11(2):382-388. doi: 10.1159/000477391. eCollection 2017 May-Aug.
7
The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?
J Gastroenterol. 2018 Feb;53(2):165-171. doi: 10.1007/s00535-017-1397-z. Epub 2017 Oct 10.
8
Optimal Histologic Cutpoints for Treatment Response in Patients With Eosinophilic Esophagitis: Analysis of Data From a Prospective Cohort Study.
Clin Gastroenterol Hepatol. 2018 Feb;16(2):226-233.e2. doi: 10.1016/j.cgh.2017.09.046. Epub 2017 Oct 4.
9
Epidemiology and Natural History of Eosinophilic Esophagitis.
Gastroenterology. 2018 Jan;154(2):319-332.e3. doi: 10.1053/j.gastro.2017.06.067. Epub 2017 Aug 1.
10
Toward More Efficient Dietary Elimination Therapy for Eosinophilic Esophagitis: The Fantastic 4?
Clin Gastroenterol Hepatol. 2017 Nov;15(11):1668-1670. doi: 10.1016/j.cgh.2017.07.022. Epub 2017 Jul 26.
Zotero 插件